Skip to main content
. Author manuscript; available in PMC: 2015 Jul 7.
Published in final edited form as: Chembiochem. 2014 May 30;15(10):1508–1513. doi: 10.1002/cbic.201402077

Table 1.

ELISA anti-MUC1 and anti-Thelper antibody titers[a] after three and four immunizations with various preparations.

Imm[b] IgG total MUC1 Imm 3 IgG total MUC1 EP IgG1 MUC1 EP IgG2a MUC1 EP IgG2b MUC1 EP IgG3 MUC1 EP IgM MUC1 EP IgG total Thelper EP
1 28 500 59 100 17 800 7000 26 800 11 300 100 300
2 700 1000 400 0 600 200 50 1000
3 7800 10 600 9000 1000 6800 5300 50 50
4 0 0 0 0 0 0 50 50
IFA 0 0 0 0 0 0 100 50
[a]

Anti-MUC1 and anti-Thelper antibody titers are presented as median values for groups of mice. ELISA plates were coated with BSA-MI-CTSAPDT-(αGalNAc)RPAP conjugate for anti-MUC1 antibody titers or NeutrAvidin-biotin-Thelper for anti-Thelper antibody titers. Titers were determined by linear regression analysis, with plotting of dilution versus absorbance. Titers are defined as the highest dilutions yielding optical densities of 0.1 or greater relative to normal control mouse sera. [b] For immunizations with 1 and 2 liposomal preparations were employed, whereas 3 and 4 were given together with IFA. MT.MUC1 tumors were induced between the third and the fourth immunization. EP indicates endpoint serum samples.